Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acute Lymphoblastic Leukemia
100%
IKZF1
100%
Copy number Variation
36%
Poor Outcome
36%
High Risk
18%
Validation Cohort
18%
B Cell Progenitors
18%
BCR-ABL1
18%
Transcription Factor
9%
Gene Expression
9%
Hypodiploidy
9%
B Cells
9%
Working Diagnosis
9%
Reduced Expression
9%
Hematopoietic Stem Cells
9%
Recurring
9%
High-risk Acute Leukemia
9%
DNA Copy number
9%
Pediatric Patients
9%
Current Therapies
9%
Genetic Modification
9%
B-lineage
9%
B Cell Development
9%
Gene Signature
9%
SNP Array
9%
Leukemia Subtype
9%
PAX5
9%
Genome-wide Analysis
9%
Ultra-high Risk
9%
Prognostic Implications
9%
Stem Cell Genes
9%
Lineage Genes
9%
IKZF1 Deletion
9%
Transcriptional Profiling
9%
Biochemistry, Genetics and Molecular Biology
B Cell
100%
IKZF1
100%
Gene Expression Profiling
40%
Single-Nucleotide Polymorphism
20%
Transcription Factors
20%
Microarrays
20%
Cell Maturation
20%
Gene Mutation
20%
Gene Dosage
20%
Cell Lineage
20%
PAX5
20%
Hematopoietic Cell
20%
Medroxyprogesterone Acetate
20%
Immunology and Microbiology
B Cell
100%
Gene Expression Assay
50%
Transcription Factors
25%
Single Nucleotide Polymorphism
25%
Gene Dosage
25%
Cell Lineage
25%
B Cell Development
25%
Gene Mutation
25%
Hematopoietic Cell
25%